Openvas Plus (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Openvas Plus, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Openvas Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Openvas Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Openvas Plus combines Olmesartan medoxomil and Hydrochlorothiazide, acting on the renin‑angiotensin‑aldosterone system to lower blood pressure. It is indicated for: - Hypertension: Improves blood pressure control when monotherapy is insufficient. - Hypertension with fluid retention: Provides additional diuretic effect to reduce edema. - Resistant‑resistant resistant ?   t

Common  t